Fasting

Opening on March 16: Largest retrospective of Marina Abramović ever held in the Netherlands opens at Stedelijk Museum Amsterdam

Retrieved on: 
Jeudi, décembre 21, 2023

After staging the major retrospective of Ulay's work in 2020, we now proudly open the doors of the museum to Marina Abramović, who has a long and meaningful relationship with the Stedelijk.

Key Points: 
  • After staging the major retrospective of Ulay's work in 2020, we now proudly open the doors of the museum to Marina Abramović, who has a long and meaningful relationship with the Stedelijk.
  • The exhibition Marina Abramović is organized by the Stedelijk Museum Amsterdam and the Royal Academy of Arts, London.
  • The version of the retrospective presented in the Netherlands was organized by curators Karen Archey and Nina Folkersma.
  • The exhibition is generously supported by Art Mentor Foundation Lucerne, the Blockbusterfonds, the benefactors of the Marina Abramović Circle, and the benefactors of the Stedelijk Museum Fonds.

Opening on March 16: Largest retrospective of Marina Abramović ever held in the Netherlands opens at Stedelijk Museum Amsterdam

Retrieved on: 
Jeudi, décembre 21, 2023

After staging the major retrospective of Ulay's work in 2020, we now proudly open the doors of the museum to Marina Abramović, who has a long and meaningful relationship with the Stedelijk.

Key Points: 
  • After staging the major retrospective of Ulay's work in 2020, we now proudly open the doors of the museum to Marina Abramović, who has a long and meaningful relationship with the Stedelijk.
  • The exhibition Marina Abramović is organized by the Stedelijk Museum Amsterdam and the Royal Academy of Arts, London.
  • The version of the retrospective presented in the Netherlands was organized by curators Karen Archey and Nina Folkersma.
  • The exhibition is generously supported by Art Mentor Foundation Lucerne, the Blockbusterfonds, the benefactors of the Marina Abramović Circle, and the benefactors of the Stedelijk Museum Fonds.

Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity

Retrieved on: 
Vendredi, décembre 1, 2023

Pfizer Inc. (NYSE: PFE) today announced topline data from the Phase 2b clinical trial ( NCT04707313 ) investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate, danuglipron (PF-06882961), in adults with obesity and without type 2 diabetes.

Key Points: 
  • Pfizer Inc. (NYSE: PFE) today announced topline data from the Phase 2b clinical trial ( NCT04707313 ) investigating its oral Glucagon-like peptide-1 receptor agonist (GLP-1RA) candidate, danuglipron (PF-06882961), in adults with obesity and without type 2 diabetes.
  • The study met its primary endpoint demonstrating statistically significant change in body weight from baseline.
  • Placebo-adjusted reductions in mean body weight ranged from -8% to -13% at 32 weeks and -5% to -9.5% at 26 weeks.
  • In both populations, danuglipron demonstrated a safety and tolerability profile consistent with the mechanism of action.

Obatala Sciences Announces Commercial Launch of Its ObaCell® Obesity-on-a-Chip Service

Retrieved on: 
Mardi, novembre 28, 2023

Obatala Sciences, a biotechnology company that manufactures stem cells and human-derived hydrogels, announced the accomplishment of a major milestone with the commercial launch of its ObaCell® Obesity-on-a-Chip Service.

Key Points: 
  • Obatala Sciences, a biotechnology company that manufactures stem cells and human-derived hydrogels, announced the accomplishment of a major milestone with the commercial launch of its ObaCell® Obesity-on-a-Chip Service.
  • The new service reflects the commercial development of a family of patents that Obatala licensed from Harvard University in 2021.
  • Obatala Sciences is the first to market a technology that enables a more holistic understanding of human adipose tissue, which is an essential organ that impacts a wide array of metabolic diseases, including obesity and diabetes.
  • Obatala Sciences’ new service offering can reproduce the physiology of obese patients in a lab in ways never possible before, by overcoming size limitations for culturing mature adipocytes in a dish and simulating fasting and feeding in a human model system.

Arrowhead Presents New Phase 2 Data on Plozasiran and Zodasiran at AHA 2023

Retrieved on: 
Lundi, novembre 13, 2023

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented new Phase 2 clinical data from the ongoing SHASTA-2 and MUIR studies of plozasiran (ARO-APOC3) and the ARCHES-2 study of zodasiran (ARO-ANG3) at the American Heart Association (AHA) Scientific Sessions 2023, being held in Philadelphia, PA, on November 11-13, 2023.

Key Points: 
  • Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today presented new Phase 2 clinical data from the ongoing SHASTA-2 and MUIR studies of plozasiran (ARO-APOC3) and the ARCHES-2 study of zodasiran (ARO-ANG3) at the American Heart Association (AHA) Scientific Sessions 2023, being held in Philadelphia, PA, on November 11-13, 2023.
  • Despite potent LDL-C lowering therapies, residual ASCVD risk persists due in part to high levels of atherogenic TRLs.
  • At 24 weeks, plozasiran durably decreased serum APOC3 to -79%, TGs to -74%, and remnant cholesterol to -63%, while increasing HDL-cholesterol to +68%.
  • Serious TEAEs were not related to plozasiran and were resolved without sequelae, except two subjects with malignancies.

Longevity Expert Dr. Paul Savage Announces the New "Longevity Report."

Retrieved on: 
Vendredi, décembre 1, 2023

CHICAGO, Dec. 1, 2023 /PRNewswire-PRWeb/ -- MDLifespan is making news again. Beta-testing of our "longevity score" online quiz to help people estimate their lifespan was an enormous success, with over 105,000 people participating within two weeks of launch. The longevity score quiz provided an "age," which was an estimate of how long you are likely to live based on family history, lifestyle choices, and your current health.

Key Points: 
  • "Longevity Report was created to educate the public and assist those interested in optimizing their health for as long as they live," says Dr. Savage.
  • "It seems that everyone is at least curious about their current health, risk factors, and estimated longevity," says MDLifespan Founder and CEO Dr. Paul Savage .
  • A second article, in the New York Post , featuring comments by Dr. Savage and links to the Longevity Report page on our website.
  • "Longevity Report was created to educate the public and assist those interested in optimizing their health for as long as they live," says Dr. Savage.

Longevity Expert Dr. Paul Savage Announces the New "Longevity Report."

Retrieved on: 
Vendredi, décembre 1, 2023

CHICAGO, Dec. 1, 2023 /PRNewswire-PRWeb/ -- MDLifespan is making news again. Beta-testing of our "longevity score" online quiz to help people estimate their lifespan was an enormous success, with over 105,000 people participating within two weeks of launch. The longevity score quiz provided an "age," which was an estimate of how long you are likely to live based on family history, lifestyle choices, and your current health.

Key Points: 
  • "Longevity Report was created to educate the public and assist those interested in optimizing their health for as long as they live," says Dr. Savage.
  • "It seems that everyone is at least curious about their current health, risk factors, and estimated longevity," says MDLifespan Founder and CEO Dr. Paul Savage .
  • A second article, in the New York Post , featuring comments by Dr. Savage and links to the Longevity Report page on our website.
  • "Longevity Report was created to educate the public and assist those interested in optimizing their health for as long as they live," says Dr. Savage.

PodcastOne's The Dr. Gundry Podcast, Hosted by Dr. Steven Gundry, Celebrates 15 Million Lifetime Downloads

Retrieved on: 
Mercredi, novembre 15, 2023

LOS ANGELES, Nov. 15, 2023 /PRNewswire/ -- The Dr. Gundry Podcast, hosted on the PodcastOne network, celebrates 15 million lifetime downloads. Created by four-time New York Times bestselling author, Dr. Steven Gundry—a pioneer in restorative medicine, founder of Gundry MD™, and a globally recognized cardiothoracic surgeon—his weekly podcast offers a wealth of science-based information. Through informative lectures and engaging conversations with esteemed experts, Dr. Gundry imparts his groundbreaking research to guide individuals in reclaiming their health by removing inflammatory foods and nourishing the microbiome.

Key Points: 
  • Airing Twice Weekly, The Dr. Gundry Podcast Empowers Listeners With Science-Based Knowledge to Restore Health & Live a Long, Vital Life
    LOS ANGELES, Nov. 15, 2023 /PRNewswire/ -- The Dr. Gundry Podcast , hosted on the PodcastOne network, celebrates 15 million lifetime downloads.
  • Created by four-time New York Times bestselling author, Dr. Steven Gundry —a pioneer in restorative medicine, founder of Gundry MD™ , and a globally recognized cardiothoracic surgeon—his weekly podcast offers a wealth of science-based information.
  • The Dr. Gundry Podcast is available on PodcastOne , Apple , IHea Amazon , Spotify , and wherever podcasts are heard.
  • The podcast series is also available on the Dr. Gundry Podcast YouTube channel as well, with a recent impressive milestone achievement of 60 million total views.

Lindora & L-Nutra Announce Partnership

Retrieved on: 
Mardi, novembre 14, 2023

LOS ANGELES, Nov. 14, 2023 /PRNewswire/ -- Lindora, Southern California's leading weight management and metabolic health practice, announces a partnership with L-Nutra Inc., the premier nutri-technology company spearheading longevity science nutrition programs. Together, L-Nutra and Lindora will use the science of Fasting Mimicking Diets (FMD) to help clients at their 31 boutiques improve their metabolic health.

Key Points: 
  • Lindora brings L-Nutra's flagship product, ProLon, to clients as part of their cardiometabolic solutions
    LOS ANGELES, Nov. 14, 2023 /PRNewswire/ -- Lindora, Southern California's leading weight management and metabolic health practice, announces a partnership with L-Nutra Inc., the premier nutri-technology company spearheading longevity science nutrition programs.
  • Together, L-Nutra and Lindora will use the science of Fasting Mimicking Diets (FMD) to help clients at their 31 boutiques improve their metabolic health.
  • "At Lindora, we are dedicated to coaching our clients in all aspects of their metabolic health journey," said Colleen Lewis, CEO of Lindora.
  • Clients who receive L-Nutra products through Lindora will be offered guidance and supervision through Lindora practitioners.

Rapaport Press Release: Rapaport Begins 3 Day Fast to Protest

Retrieved on: 
Jeudi, novembre 9, 2023

Despite its history of human rights abuses related to its diamond sector, Zimbabwe is the current head of the Kimberley Process.

Key Points: 
  • Despite its history of human rights abuses related to its diamond sector, Zimbabwe is the current head of the Kimberley Process.
  • The World Diamond Council is also closely associated and shares directors with the Responsible Jewelry Council, whose members include major jewelry brands.
  • "The World Diamond Council supports the Kimberley Process certification scheme, approving the trade in Russian diamonds and other diamonds associated with human rights abuses.
  • The WDC has no red lines.”
    “WDC representatives are feasting in Zimbabwe with government officials as many Zimbabweans starve due to government corruption,” said Rapaport.